Back
Smith & Nephew PLC Vs. Adaptimmune Therapeutics PLC Industry Stock Comparison
Sell
25
SNNUF
Smith & Nephew PLC
Last Price:
$14.21
Seasonality Move:
-0.67%
Sell
29
ADAP
Adaptimmune Therapeutics PLC
Last Price:
$0.28
Seasonality Move:
-2.23%
Sell
25
Smith & Nephew PLC (SNNUF)
is a Sell
Is Smith & Nephew PLC a Buy, Sell or Hold?
-
The current Smith & Nephew PLC [SNNUF] share price is $14.21. The Score for SNNUF is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
-
SNNUF is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
29
Adaptimmune Therapeutics PLC (ADAP)
is a Sell
Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?
-
The current Adaptimmune Therapeutics PLC [ADAP] share price is $0.29. The Score for ADAP is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
-
ADAP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SNNUF Stock Price Chart
What is Smith & Nephew PLC's stock price today?
-
The Smith & Nephew PLC share price today is $14.21The current trend is moderately bullish and SNNUF is experiencing slight buying pressure.
ADAP Stock Price Chart
What is Adaptimmune Therapeutics PLC's stock price today?
-
The Adaptimmune Therapeutics PLC share price today is $0.29The current trend is relatively stagnant and ADAP is experiencing buying pressure, which is a positive indicator for future bullish movement.
SNNUF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.12 | Buy |
Relative Strength Index (14 RSI): | 54.11 | Buy |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (13.71 - 14.55) | Buy |
Bollinger Bands (100): | (12.67 - 14.51) | Buy |
ADAP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0 | Sell |
Relative Strength Index (14 RSI): | 53.91 | Buy |
Chaikin Money Flow: | 696056 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.27 - 0.29) | Buy |
Bollinger Bands (100): | (0.25 - 0.57) | Sell |
SNNUF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 14.21 | Sell |
20-day SMA: | 14.3 | Sell |
50-day SMA: | 13.95 | Buy |
200-day SMA: | 13.72 | Buy |
8-day EMA: | 14.25 | Sell |
20-day EMA: | 14.17 | Buy |
50-day EMA: | 13.96 | Buy |
200-day EMA: | 13.61 | Buy |
ADAP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.28 | Buy |
20-day SMA: | 0.28 | Buy |
50-day SMA: | 0.27 | Buy |
200-day SMA: | 0.64 | Sell |
8-day EMA: | 0.28 | Buy |
20-day EMA: | 0.28 | Buy |
50-day EMA: | 0.31 | Sell |
200-day EMA: | 0.57 | Sell |
Smith & Nephew PLC Earnings Growth & SNNUF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.36 per share, and an increase next year of $0.01 per share.
Smith & Nephew PLC Technical Analysis
May 16 | May 19 | May 20 | May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
16 | 19 | 20 | 21 | 22 | 23 | 27 | 28 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Adaptimmune Therapeutics PLC Technical Analysis
May 16 | May 19 | May 20 | May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
16 | 19 | 20 | 21 | 22 | 23 | 27 | 28 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |